Severe tacrolimus toxicity in rabbits

Experimental and Clinical Transplantation

Volumn 5, Issue 1, 2007, Pages 590-595

  Giessler, Goetz A ^a   Gades, Naomi M ^a   Friedrich, Patricia F ^a   Bishop, Allen T ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adverse effect; Adverse event; Bone allograft; FK 506; Immunosuppression

Indexed keywords

TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE TRANSPLANTATION; CARDIOPULMONARY INSUFFICIENCY; CONTROLLED STUDY; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG MONITORING; DRUG SAFETY; FEMUR; GRAFT REJECTION; HEART DISEASE; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LUNG EDEMA; LUNG HEMORRHAGE; NONHUMAN; PERITONEUM EXUDATE; RABBIT; SURGICAL MORTALITY; SURVIVAL RATE; TOXICITY TESTING; TREATMENT DURATION; WEIGHT REDUCTION; ANIMAL; BLOOD; DOSE RESPONSE; GRAFT SURVIVAL; INTRAMUSCULAR DRUG ADMINISTRATION; MORTALITY; SPECIES DIFFERENCE; SURVIVAL; TRANSPLANTATION; VASCULARIZATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMUR; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAMUSCULAR; MORTALITY; RABBITS; SPECIES SPECIFICITY; SURVIVAL ANALYSIS; TACROLIMUS;

EID: 34547471998     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Pelzer M, Larsen M, Chung YG, Ohno T, Platt JL, Friedrich PF, Bishop AT. Short-term immunosuppression and surgical neoangiogenesis with host vessels maintains long-term viability of vascularized bone allografts. J Orthop Res 2006; 25: 370-377
2. Suzuki O, Bishop AT, Sunagawa T, Katsube K, Friedrich PF. VEGF-promoted surgical angiogenesis in necrotic bone. Microsurgery 2004; 24: 85-91
3. Muramatsu K, Kurokawa Y, Kuriyama R, Taguchi T, Bishop AT. Gradual graft-cell repopulation with recipient cells following vascularized bone and limb allotransplantation. Microsurgery 2005; 25: 599-605
4. Muramatsu K, Bishop AT, Sunagawa T, Valenzuela RG. Fate of donor cells in vascularized bone grafts: identification of systemic chimerism by the polymerase chain reaction. Plast Reconstr Surg 2003; 111: 763-772; discussion 773-764
5. Bishop AT, Pelzer M. Vascularized bone allotransplantation: current state and implications for future reconstructive surgery: Orthop Clin North Am 2007; 38: 109-122, vii
6. Nomoto S, Fujiwara H, Ban T, Ohara K. Cardiotoxicity of long-term intravenous administration of FK506 in rabbits: dose relationship and recovery after discontinuance. Transplant Proc 1994; 26: 855-857
7. Piekoszewski W, Chow FS, Jusko WJ. Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance. Drug Metab Dispos 1993; 21: 690-698.
8. Piekoszewski W, Chow FS, Jusko WJ. Pharmacokinetic and pharmacodynamic effects of coadministration of methyl-prednisolone and tacrolimus in rabbits. J Pharmacol Exp Ther 1994; 269: 103-109
9. Ikebe S, Masumi S, Yano H, Fukunaga T, Shimizu K, Shin S. Immunosuppressive effect of tacrolimus (FK-506). Bone xenografts in rabbits. Acta Orthop Scand 1996; 67: 389-392
10. Minamino T, Kitakaze M, Ueda Y, Asanuma H, Papst PJ, Kuzuya T, et al. Chronic treatment with FK506 increases p70 S6 kinase activity associated with reduced nitric oxide synthase activity in rabbit hearts. Cardiovasc Drugs Ther 2000; 14: 329-336
11. Hisamatsu C, Maeda K, Tanaka H, Okita Y. Transplantation of the cryopreserved tracheal allograft in growing rabbits: effect of immunosuppressant. Pediatr Surg Int 2006; 22: 881-885
12. Guide for the care and use of laboratory animals. 6th ed. Washington, DC: National Academy Press, 1996
13. Kniha H, Randzio J, Gold ME, Fudem GM, Cruz HG, Park HH, Fumas DW. Growth of forelimb allografts in young rabbits immunosuppressed with cyclosporine. Ann Plast Surg 1989; 22: 135-141
14. Randzio J, Kniha H, Gold ME, Chang TT, Su LD, Park HH,et al. Growth of vascularized composite mandibular allografts in young rabbits. Ann Plast Surg 1991; 26: 140-148
15. Morrison WA, Dvir E, Doi K, Hurley JV, Hickey MJ, O'Brien BM. Prefabrication of thin transferable axial-pattern skin flaps: an experimental study in rabbits. Br J Plast Surg 1990; 43: 645-654
16. Hoang NT, Kloeppel M, Staudenmaier R, Werner J, Biemer E. Prefabrication of large fasciocutaneous flaps using an isolated arterialised vein as implanted vascular pedicle. Br J Plast Surg 2005; 58: 632-639
17. Nakatani T, Uchida J, Iwai T, Matsumura K, Naganuma T, Kuratsukuri K, Sugimura K. Renin mRNA expression and renal dysfunction in tacrolimus-induced acute nephrotoxicity. Int J Mol Med 2003; 11: 75-78
18. Akar Y, Yucel G, Durukan A, Yucel I, Arici G. Systemic toxicity of tacrolimus given by various routes and the response to dose reduction. Clin Experiment Ophthalmol 2005; 33: 53-59
19. Ochiai T, Gunji Y, Sakamoto K, Suzuki T, Isegawa N, Asano T, Isono K. Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog. Transplantation 1989; 48: 189-193
20. Ochiai T, Nagata M, Nakajima K, Suzuki T, Sakamoto K, Enomoto K, et al. Studies of the effects of FK506 on renal allografting in the beagle dog. Transplantation 1987; 44: 729-733
21. Morimoto T, Yamada F, Kobayashi T, Iwasaki K, Sunada M, Sakamoto J, et al. Blood levels of FK506 after intramuscular and intravenous administration in dogs. Transplant Proc 1989; 21: 1059-1063
22. Wang X, Sun H, Chen G, Liu W, Wise Y, Yung C, et al. Immunosuppression with a combination of pg490-88 and a subtherapeutic dose of FK506 in a canine renal allograft model. Transplantation 2005; 79: 1537-1544
23. Shirbacheh MV, Jones JW, Harralson TA, Edelstein J, Tecimer T, Breidenbach WC, et al. Pharmacokinetics of intra-arterial delivery of tacrolimus to vascularly isolated rabbit forelimb. J Pharmacol Exp Ther 1999; 289: 1196-1201
24. McMaster P, Mirza DF, Ismail T, Vennarecci G, Patapis P, Mayer AD. Therapeutic drug monitoring of tacrolimus in clinical transplantation. Ther Drug Monit 1995; 17: 602-605
25. Chow FS, Piekoszewski W, Jusko WJ. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion. Drug Metab Dispos 1997; 25: 610-616
26. Ochiai T, Nakajima K, Nagata M, Suzuki T, Asano T, Uematsu T, et al. Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat. Transplant Proc 1987; 19: 1284-1286
27. Gohda T, Iwasaki N, Yoshioka C, Minami A. Effect of single-dose administration of FK-506 on allogeneic limb transplantation in rats: is there an optimal timing of its administration? Plast Reconstr Surg 2003; 111: 1653-1658
28. Akst LM, Siemionow M, Dan O, Izycki D, Strome M. Induction of tolerance in a rat model of laryngeal transplantation. Transplantation 2003; 76: 1763-1770
29. Inoue T, Kawamura I, Matsuo M, Aketa M, Mabuchi M, Seki J, Goto T. Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats. Transplantation 2000; 70: 774-779
30. Fukunaga T, Masumi S, Yano H, Ikebe S, Shimizu K. Osteogenesis in xenogeneic bone transplantation, using an immunosuppressant. Rabbit-rat experiments. Acta Orthop Scand 1995; 66: 557-560
31. Venkataramanan R, Warty VS, Zemaitis MA, Sanghvi AT, Burckart GJ, Seltman H, et al. Biopharmaceutical aspects of FK506. Transplant Proc 1987; 19: 30-35
32. Oike F, Talpe S, Otsuka M, Dehoux JP, Lerut J, Otte JB, Gianello P. A 12-day course of FK506 allows long-term acceptance of semi-identical liver allograft in inbred miniature swine. Transplantation 2000; 69: 2304-2314